Learn More
Invitrogen™ Human LXR alpha (aa 318-329) Synthetic Peptide
Description
PEP-114 is a 12 amino acid synthetic peptide whose sequence corresponds to residues 318-329 of human LXR alpha with an amino-terminal cysteine added for carrier protein conjugation. The sequence of this peptide is (amino to carboxy terminus): C-D318-F-S-Y-N-R-E-D-F-A-K-A (329). This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human LXR alpha, catalog # PA1-330. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (~70-fold) for competitive inhibition of antibody-protein binding reactions. Reconstitute with 0.1 mL of distilled water.
Spécifications
Spécifications
| ID du gène (Entrez) | 10062 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d'enregistrement | Q13133 |
| Nom usuel | LXR alpha |
| Concentration | 0.5 mg/mL |
| Contenu et stockage | -20°C. Avoid freeze-thaw cycles. |
| Aperçu général | Synthetic Peptide |
| Format | Lyophilized |
| Formule | Peptide with no preservative |
| Afficher plus de résultats |